A citation-based method for searching scientific literature

A van Erkelens, A S Sie, P Manders, A Visser, L E Duijm, R M Mann, M Ten Voorde, H Kroeze, J B Prins, N Hoogerbrugge. Eur J Cancer 2017
Times Cited: 9







List of co-cited articles
35 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The current state of cancer family history collection tools in primary care: a systematic review.
Nadeem Qureshi, June C Carroll, Brenda Wilson, Pasqualina Santaguida, Judith Allanson, Melissa Brouwers, Parminder Raina. Genet Med 2009
71
33

The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care.
J Emery, H Morris, R Goodchild, T Fanshawe, A T Prevost, M Bobrow, A L Kinmonth. Br J Cancer 2007
76
33

Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial.
Wendy S Rubinstein, Louise S Acheson, Suzanne M O'Neill, Mack T Ruffin, Catharine Wang, Jennifer L Beaumont, Nan Rothrock. Genet Med 2011
65
33

Breast cancer risk feedback to women in the UK NHS breast screening population.
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
48
33




Family history questionnaires designed for clinical use: a systematic review.
G T Reid, F M Walter, J M Brisbane, J D Emery. Public Health Genomics 2009
56
22

Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial.
Mack T Ruffin, Donald E Nease, Ananda Sen, Wilson D Pace, Catharine Wang, Louise S Acheson, Wendy S Rubinstein, Suzanne O'Neill, Robert Gramling. Ann Fam Med 2011
104
22

Familial risk for common diseases in primary care: the Family Healthware Impact Trial.
Suzanne M O'Neill, Wendy S Rubinstein, Catharine Wang, Paula W Yoon, Louise S Acheson, Nan Rothrock, Erin J Starzyk, Jennifer L Beaumont, James M Galliher, Mack T Ruffin. Am J Prev Med 2009
88
22

Collecting genetic information in primary care: evaluating a new family history tool.
Nadeem Qureshi, Jane Bethea, Bernadette Modell, Paul Brennan, Alexia Papageorgiou, Sandy Raeburn, Rhydian Hapgood, Michael Modell. Fam Pract 2005
66
22

A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians.
Maren T Scheuner, Alison B Hamilton, Jane Peredo, Taylor J Sale, Colletta Austin, Stuart C Gilman, M Scott Bowen, Caroline Lubick Goldzweig, Martin Lee, Brian S Mittman,[...]. Genet Med 2014
34
22

Protocol for implementation of family health history collection and decision support into primary care using a computerized family health history system.
Lori A Orlando, Elizabeth R Hauser, Carol Christianson, Karen P Powell, Adam H Buchanan, Blair Chesnut, Astrid B Agbaje, Vincent C Henrich, Geoffrey Ginsburg. BMC Health Serv Res 2011
40
22

Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial.
R Ryanne Wu, Lori A Orlando, Tiffany L Himmel, Adam H Buchanan, Karen P Powell, Elizabeth R Hauser, Astrid B Agbaje, Vincent C Henrich, Geoffrey S Ginsburg. BMC Fam Pract 2013
40
22

Developing Family Healthware, a family history screening tool to prevent common chronic diseases.
Paula W Yoon, Maren T Scheuner, Cynthia Jorgensen, Muin J Khoury. Prev Chronic Dis 2009
105
22

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
696
22


Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Jill Knox, Simon Cawthorn, Christobel Saunders, Nicola Roche, Robert E Mansel, Gunter von Minckwitz,[...]. Lancet 2014
352
22

Assessing and managing breast cancer risk: clinicians' current practice and future needs.
Ian M Collins, Emma Steel, G Bruce Mann, Jon D Emery, Adrian Bickerstaffe, Alison Trainer, Phyllis Butow, Marie Pirotta, Antonis C Antoniou, Jack Cuzick,[...]. Breast 2014
32
22

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
Jack Cuzick, Ivana Sestak, Bernardo Bonanni, Joseph P Costantino, Steve Cummings, Andrea DeCensi, Mitch Dowsett, John F Forbes, Leslie Ford, Andrea Z LaCroix,[...]. Lancet 2013
279
22

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
319
22

Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Linda Rainey, Daniëlle van der Waal, Louise S Donnelly, D Gareth Evans, Yvonne Wengström, Mireille Broeders. PLoS One 2018
18
22

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017
101
22

The genomic medicine model: an integrated approach to implementation of family health history in primary care.
Lori A Orlando, Vincent C Henrich, Elizabeth R Hauser, Charles Wilson, Geoffrey S Ginsburg. Per Med 2013
18
22

Family history assessment: impact on disease risk perceptions.
Catharine Wang, Ananda Sen, Mack T Ruffin, Donald E Nease, Robert Gramling, Louise S Acheson, Suzanne M O'Neill, Wendy S Rubinstein. Am J Prev Med 2012
38
22


Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
22

Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.
D Gareth Evans, Adam R Brentnall, Michelle Harvie, Sarah Dawe, Jamie C Sergeant, Paula Stavrinos, Susan Astley, Mary Wilson, John Ainsworth, Jack Cuzick,[...]. Cancer Prev Res (Phila) 2014
21
22

Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
Elke M van Veen, Adam R Brentnall, Helen Byers, Elaine F Harkness, Susan M Astley, Sarah Sampson, Anthony Howell, William G Newman, Jack Cuzick, D Gareth R Evans. JAMA Oncol 2018
64
22

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
125
22

Psychological impact of providing women with personalised 10-year breast cancer risk estimates.
David P French, Jake Southworth, Anthony Howell, Michelle Harvie, Paula Stavrinos, Donna Watterson, Sarah Sampson, D Gareth Evans, Louise S Donnelly. Br J Cancer 2018
27
22

Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey.
Alex Ghanouni, Saskia C Sanderson, Nora Pashayan, Cristina Renzi, Christian von Wagner, Jo Waller. J Med Screen 2020
15
22

Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.
Susanne F Meisel, Nora Pashayan, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. Breast 2015
35
22

Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer.
Natalie J Engmann, Marzieh K Golmakani, Diana L Miglioretti, Brian L Sprague, Karla Kerlikowske. JAMA Oncol 2017
108
22

The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
494
22

Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Daniel L Worthley, Alicia Smith, Peter A Bampton, Stephen R Cole, Graeme P Young. Eur J Gastroenterol Hepatol 2006
9
11

A randomized, controlled trial to increase discussion of breast cancer in primary care.
Celia P Kaplan, Jennifer Livaudais-Toman, Jeffrey A Tice, Karla Kerlikowske, Steven E Gregorich, Eliseo J Pérez-Stable, Rena J Pasick, Alice Chen, Jessica Quinn, Leah S Karliner. Cancer Epidemiol Biomarkers Prev 2014
23
11

Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome.
P Manders, L Spruijt, C M Kets, H W Willems, D Bodmer, K M Hebeda, I D Nagtegaal, J H J M van Krieken, M J L Ligtenberg, N Hoogerbrugge. Eur J Cancer 2011
10
11

Milestones of Lynch syndrome: 1895-2015.
Henry T Lynch, Carrie L Snyder, Trudy G Shaw, Christopher D Heinen, Megan P Hitchins. Nat Rev Cancer 2015
385
11

Colorectal cancer screening in countries of European Council outside of the EU-28.
Emma Altobelli, Francesco D'Aloisio, Paolo Matteo Angeletti. World J Gastroenterol 2016
37
11

Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing?
C Wong, P Gibbs, J Johns, I Jones, I Faragher, E Lynch, F Macrae, L Lipton. Intern Med J 2008
31
11


A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects.
P Spinhoven, J Ormel, P P Sloekers, G I Kempen, A E Speckens, A M Van Hemert. Psychol Med 1997
11

Most patients with colorectal tumors at young age do not visit a cancer genetics clinic.
Lucia I H Overbeek, Nicoline Hoogerbrugge, Joannes H J M van Krieken, Fokko M Nagengast, Theo J M Ruers, Marjolijn J L Ligtenberg, Rosella P M G Hermens. Dis Colon Rectum 2008
28
11


The Hospital Anxiety and Depression Scale: a meta confirmatory factor analysis.
Sam Norton, Theodore Cosco, Frank Doyle, John Done, Amanda Sacker. J Psychosom Res 2013
244
11

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
J Ferlay, E Steliarova-Foucher, J Lortet-Tieulent, S Rosso, J W W Coebergh, H Comber, D Forman, F Bray. Eur J Cancer 2013
11

Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system.
Sharon S Laing, Andy Bogart, Jessica Chubak, Sharon Fuller, Beverly B Green. Cancer Epidemiol Biomarkers Prev 2014
22
11

Tumor spectrum in lynch syndrome, DNA mismatch repair system and endogenous carcinogens.
Vicente Medina-Arana, Luciano Delgado, Alberto Bravo, Juana Martín, Antonia M Fernández-Peralta, Juan J González-Aguilera. J Surg Oncol 2012
7
14

Accuracy of family history of cancer: clinical genetic implications.
R H Sijmons, A E Boonstra, J Reefhuis, J M Hordijk-Hos, H E de Walle, J C Oosterwijk, M C Cornel. Eur J Hum Genet 2000
77
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.